Estesa università multidisciplinare con edifici importanti, oltre a musei e giardini botanici.

During the past decade, University of Turin conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 4 clinical trials were completed, i.e. on average, 21.1% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 3 clinical trials were completed. i.e. 23.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Turin" #1 sponsor was "University of Turin, Italy" with 7 trials, followed by "Alexion" with 2 trials sponsored, "Amylyx Pharmaceuticals Inc." with 2 trials sponsored, "ElectroCore INC" with 2 trials sponsored and "Alberto Peano" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Turin" #1 collaborator was "Azienda Sanitaria Locale Roma E" with 1 trials as a collaborator, "European Research Council" with 1 trials as a collaborator, "Italian Society for Rheumatology" with 1 trials as a collaborator, "LIPODOM THERAPEUTICS" with 1 trials as a collaborator and "Laboratory Corporation of America" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "University of Turin" are "Amyotrophic Lateral Sclerosis" (3 trials), "Migraine" (2 trials), "Prostate Cancer" (2 trials), "ALS" (1 trials) and "Activation of the Sonic Hedgehog (SHH) Pathway" (1 trials). Many other conditions were trialed in "University of Turin" in a lesser frequency.

Most popular intervention types in "University of Turin" are "Drug" (13 trials), "Device" (5 trials), "Procedure" (4 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "AMX0035" (2 trials), "Placebo" (2 trials), "Soft tissue augmentation with subepithelial connective tissue graft (SCTG)" (2 trials), "4-Ports Cholecystectomy (4PC)" (1 trials) and "Behavioral therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Turin" are 25 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University of Turin". undefined are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 11 completed trials in University of Turin, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in University of Turin, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 6 trials that are defined as “Not Applicable".